MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates

MannKind (MNKD) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of$ 0.02 per share. This compares to loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 150%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.01 per share when it actually produced earnings of $0.02, delivering a surprise of 300%.Over the last four quarters, the company ...